← SynDRA
MOLIDUSTAT
SynDRA canonical compound SYN0038361 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | EGLN2 |
|---|
| Mechanism of action | hypoxia inducible factor inhibitor |
|---|
All known targets
- EGLN2
- EGLN3
- EGLN1
- A085R
- HIF1AN
Mechanisms of action (all sources)
- EGLN1 INHIBITOR
- Egl nine homolog 1 inhibitor
- EGLN2 INHIBITOR
- Hypoxia-inducible factor prolyl hydroxylase 1 inhibitor
- EGLN3 INHIBITOR
- Egl nine homolog 3 inhibitor
- hypoxia inducible factor inhibitor
ATC classes
- B03X · OTHER ANTIANEMIC PREPARATIONS
Cross-references
Synonyms
- molidustat sodium
- musredo
- BAY 85-3934
- BAY-85-3934
- Hypoxia-inducible factor prolyl hydroxylase inhibitors (anemia)
- HIF-PH inhibitors (anemia), Bayer
- BAY-853934
- Molidustat (BAY85-3934)
- BAY85-3934
- UNII-9JH486CZ13
- Molidustat(BAY 85-3934)
- 9JH486CZ13
- 2-(6-morpholin-4-ylpyrimidin-4-yl)-4-(triazol-1-yl)-1H-pyrazol-3-one
- 3H-Pyrazol-3-one, 1,2-dihydro-2-[6-(4-morpholinyl)-4-pyrimidinyl]-4-(1H-1,2,3-triazol-1-yl)-
- 2-(6-Morpholinopyrimidin-4-yl)-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-3(2H)-one
- 2-[6-(4-Morpholinyl)-4-pyrimidinyl]-4-(1H-1,2,3-triazol-1-yl)-1,2-dihydro-3H-pyrazol-3-one
- 2-(6-morpholin-4-ylpyrimidin-4-yl)-4-(1,2,3-triazol-1-yl)pyrazol-3-ol
- 2-(6-Morpholin-4-Ylpyrimidin-4-Yl)-4-(1,2,3-Triazol-1-Yl)-1~{h}-Pyrazol-3-One
- Molidustat [INN]
- Molidustat(BAY85-3934)
- Molidustat (BAY 85-3934)
- QEQ
- GTPL8456
- SCHEMBL2569970
- SCHEMBL6114312
- CHEMBL3646118
- CHEMBL3991036
- DTXSID80151089
- EX-A562
- BDBM118339
- AOB87194
- BCP14477
- MFCD28411428
- AKOS026750584
- ZINC167006010
- CCG-267626
- SB17156
- NCGC00388364-04
Look up MOLIDUSTAT in the interactive SynDRA portal →